
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
This publication provides a comprehensive and up-to-date review of the significance of cytogenetic and molecular genetic abnormalities in the chronic myeloid leukaemias and other myeloproliferative disorders. Subjects discussed include polycythaemia vera, essential thrombocythaemia, 'idiopathic' myelofibrosis and BCR-ABL-positive chronic myeloid leukaemia. The role of cytogenetic and molecular genetic analysis in monitoring residual disease in chronic myeloid leukaemia is also comprehensively covered. In addition, the less common entities of the 8p11 syndrome, systemic mastocytosis, eosinophilic leukaemia and chronic myeloid leukaemia associated with t(5;12) are reviewed in detail. With the development of drugs with a specific molecular target, molecular aspects of chronic leukaemias will become increasingly relevant to the practice of haematology, making this publication very timely. The contributing authors include leaders in the fields of haematology and cytogenetics who have carefully reviewed and updated published data and drawn on their own considerable experience. This book will therefore be a reference text, not only for haematologists, but also for molecular geneticists and cytogeneticists, and anyone involved in leukaemia research.
This publication investigates the critical role of genetic abnormalities in understanding and managing chronic myeloid leukaemias and other myeloproliferative disorders. The book offers a comprehensive review of conditions such as polycythaemia vera, essential thrombocythaemia, 'idiopathic' myelofibrosis, and BCR-ABL-positive chronic myeloid leukaemia, detailing the significance of cytogenetic and molecular genetic findings. It also addresses the monitoring of residual disease in chronic myeloid leukaemia and explores less common entities like the 8p11 syndrome, systemic mastocytosis, eosinophilic leukaemia, and chronic myeloid leukaemia associated with t(5;12). The authors, leaders in hematology and cytogenetics, present updated data and their extensive experience, making this a timely reference for practitioners and researchers.
This publication is positioned as a timely and essential reference text for professionals in hematology, molecular genetics, and cytogenetics. The contributing authors are recognized leaders in their fields, lending significant authority to the reviewed data and experienced insights presented. Its comprehensive scope, covering both common and rare myeloproliferative disorders and the critical role of genetic monitoring, makes it a valuable resource for those engaged in leukemia research and clinical practice. The focus on molecular aspects is particularly relevant given the advancements in targeted therapies.
Page Count:
132
Publication Date:
2002-01-01
ISBN-10:
3805573073
ISBN-13:
9783805573078
No comments yet. Be the first to share your thoughts!